Free tool
Diagnostics stocks
We cover 8 companies grouped under the Diagnostics theme. The median market value in the group is $366.00M. Across the group, the median move over the past trading day is −0.24%. Price change over the past year runs from −30.7% to +50.7% across the middle 80 percent of the group, with a median of −12.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +39.19% | Oct 20, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% | Oct 28, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $339.65M | Small cap | +77.61% | Nov 9, 2026 |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% | Nov 12, 2026 |
| 0RAR.L | Stratec SE | $275.63M | Small cap | −14.98% | Nov 12, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.